The Use of Rectal Balloon During the Delivery of Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer: More Than Just a Prostate Gland Immobilization Device?

PURPOSEThe purpose of this study was to investigate the role of a rectal balloon for prostate immobilization and rectal toxicity reduction in patients receiving dose-escalated intensity-modulated radiotherapy for prostate cancer. PATIENTS AND METHODSPatients with localized prostate cancer who were undergoing intensity-modulated radiotherapy were treated in a prone position, immobilized with a customized Vac-Lok bag (MED-TEC, Orange City, IA). A rectal balloon with 100 cc of air was used to immobilize the prostate. The prostate displacements were measured using computed tomography (CT)-CT fusion on 10 patients who received radioactive seed implant before intensity-modulated radiotherapy. They were scanned twice weekly during 5 weeks of intensity-modulated radiotherapy, and breathing studies were also performed. Rectal toxicity was evaluated by use of Radiation Therapy Oncology Group scoring in 100 patients. They were treated to a mean dose of 76 Gy over 35 fractions (2.17-Gy fraction size). Dose-volume histogram of the rectum was assessed. A film phantom was constructed to simulate the 4-cm diameter air cavity that was created by the rectal balloon. Kodak XV2 films (Rochester NY) were used to measure and compare dose distribution with and without the air cavity. A fraction of 1.25 Gy was delivered to the phantom at isocenter with 15-MV photons by use of the NOMOS Peacock system and the MIMiC treatment delivery system (Sewickley, PA). RESULTSThe anterior-posterior and lateral prostate displacements were minimal, on the order of measurement uncertainty (∼1 mm). The standard deviation of superior-inferior displacement was 1.78 mm. Breathing studies showed no organ displacement during normal breathing when the rectal balloon was in place. The rectal toxicity profile was very favorable: 83% (83/100) patients had no rectal complaint, and 11% and 6% had grade 1 and 2 toxicity, respectively. Dose-volume histogram analysis revealed that in all of the patients, no more than 25% of the rectum received 70 Gy or greater. As visualized by film dosimetry, the dose at air-tissue interface was approximately 15% lower than that without an air cavity. The dose built up rapidly so that at 1 and 2 mm, the differential was approximately 8% and 5%, respectively. The dosimetric coverage at the depth of the posterior prostate wall was essentially equal, with or without the air cavity. DISCUSSIONThe use of a rectal balloon during intensity-modulated radiotherapy significantly reduces prostate motion. Prostate immobilization thus allows a safer and smaller planning target volume margin. It has also helped spare the anterior rectal wall (by its dosimetric effects) and reduced the rectal volume that received high-dose radiation (by rectal wall distension). All these factors may have further contributed to the decreased rectal toxicity achieved by intensity-modulated radiotherapy, despite dose escalation and higher-than-conventional fraction size.

[1]  J. Manola,et al.  A practical method to achieve prostate gland immobilization and target verification for daily treatment. , 2001, International journal of radiation oncology, biology, physics.

[2]  Warren D. D'Souza,et al.  Is the α/β ratio for prostate cancer low? , 2001 .

[3]  J. Fowler,et al.  A simple analytic derivation suggests that prostate cancer α/β ratio is low , 2001 .

[4]  Rick Chappell,et al.  Is α/β for prostate tumors really low? , 2001 .

[5]  K. Langen,et al.  Organ motion and its management. , 2001, International journal of radiation oncology, biology, physics.

[6]  E. B. Butler,et al.  Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. , 2001, International journal of radiation oncology, biology, physics.

[7]  G Starkschall,et al.  Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  D. Johnston,et al.  Detailed mapping of prostate carcinoma foci , 2000, Cancer.

[9]  A Pollack,et al.  Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. , 2000, International journal of radiation oncology, biology, physics.

[10]  J M Balter,et al.  A comparison of ventilatory prostate movement in four treatment positions. , 2000, International journal of radiation oncology, biology, physics.

[11]  D. Brenner Toward optimal external-beam fractionation for prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[12]  W. Grant,et al.  A clinical evaluation of setup errors for a prostate immobilization system , 2000, Journal of applied clinical medical physics.

[13]  C. Yu,et al.  A systematic evaluation of air cavity dose perturbation in megavoltage x-ray beams. , 2000, Medical physics.

[14]  T R Willoughby,et al.  Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland. , 2000, International journal of radiation oncology, biology, physics.

[15]  E. B. Butler,et al.  Intensity modulated radiation therapy (IMRT): a new promising technology in radiation oncology. , 1999, The oncologist.

[16]  Duchesne Gm,et al.  What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. , 1999 .

[17]  D P Dearnaley,et al.  Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. , 1999, International journal of radiation oncology, biology, physics.

[18]  D J Brenner,et al.  Fractionation and protraction for radiotherapy of prostate carcinoma. , 1999, International journal of radiation oncology, biology, physics.

[19]  T E Schultheiss,et al.  A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[20]  P. Levendag,et al.  Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study. , 1999, International journal of radiation oncology, biology, physics.

[21]  D. Dearnaley,et al.  Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial , 1999, The Lancet.

[22]  J A Antolak,et al.  Prostate target volume variations during a course of radiotherapy. , 1998, International journal of radiation oncology, biology, physics.

[23]  P. Bergström,et al.  High-precision conformal radiotherapy (HPCRT) of prostate cancer--a new technique for exact positioning of the prostate at the time of treatment. , 1998, International journal of radiation oncology, biology, physics.

[24]  T E Schultheiss,et al.  Daily CT localization for correcting portal errors in the treatment of prostate cancer. , 1998, International journal of radiation oncology, biology, physics.

[25]  William R. Fair,et al.  DOSE ESCALATION WITH THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AFFECTS THE OUTCOME IN PROSTATE CANCER , 1998 .

[26]  T E Schultheiss,et al.  Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. , 1998, International journal of radiation oncology, biology, physics.

[27]  L. Gras,et al.  Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. , 1998, International journal of radiation oncology, biology, physics.

[28]  A. Horwich,et al.  [Intensity modulated radiation therapy] , 1998, Igaku butsuri : Nihon Igaku Butsuri Gakkai kikanshi = Japanese journal of medical physics : an official journal of Japan Society of Medical Physics.

[29]  A. Pollack,et al.  External beam radiotherapy dose response of prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[30]  G J Kutcher,et al.  Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. , 1997, International journal of radiation oncology, biology, physics.

[31]  G Starkschall,et al.  Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. , 1996, International journal of radiation oncology, biology, physics.

[32]  K L Lam,et al.  Automated localization of the prostate at the time of treatment using implanted radiopaque markers: technical feasibility. , 1995, International journal of radiation oncology, biology, physics.

[33]  C. Pelizzari,et al.  Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. , 1995, International journal of radiation oncology, biology, physics.

[34]  J. Crook,et al.  Prostate motion during standard radiotherapy as assessed by fiducial markers. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[36]  E. B. Butler,et al.  Does the "peacock" have anything to do with radiotherapy? , 1994, International journal of radiation oncology, biology, physics.

[37]  P. Rubin,et al.  Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. , 1991, International journal of radiation oncology, biology, physics.

[38]  S L Schoeppel,et al.  Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. , 1991, International journal of radiation oncology, biology, physics.

[39]  A. Swan,et al.  Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984). , 1990, Urology.

[40]  G E Hanks,et al.  The effect of dose on local control of prostate cancer. , 1988, International journal of radiation oncology, biology, physics.

[41]  B. Jones,et al.  Is the alpha/beta for prostate tumors really low? In regard to Fowler et al., IJROBP 2001;50:1021-1031. , 2002, International journal of radiation oncology, biology, physics.

[42]  D. Brenner,et al.  Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue , 2002 .

[43]  R. Pötter,et al.  The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. , 2002, International journal of radiation oncology, biology, physics.

[44]  J. Fowler,et al.  A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low. , 2001, International journal of radiation oncology, biology, physics.

[45]  W. D'Souza,et al.  Is the alpha/beta ratio for prostate cancer low? , 2001, International journal of radiation oncology, biology, physics.

[46]  A. Markoe,et al.  Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. , 2000, International journal of radiation oncology, biology, physics.

[47]  A. Hanlon,et al.  Rectal bleeding after conformal 3D treatment of prostate cancer: time to occurrence, response to treatment and duration of morbidity. , 1997, International journal of radiation oncology, biology, physics.

[48]  J Pouliot,et al.  Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. , 1997, International journal of radiation oncology, biology, physics.

[49]  A. Hanlon,et al.  Late GI and GU complications in the treatment of prostate cancer. , 1997, International journal of radiation oncology, biology, physics.

[50]  K Lam,et al.  Measurement of prostate movement over the course of routine radiotherapy using implanted markers. , 1995, International journal of radiation oncology, biology, physics.

[51]  W. van Putten,et al.  Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. , 1990, International journal of radiation oncology, biology, physics.